INVO Bioscience Product Information
INVO Bioscience's INVOcell will revolutionize the treatment of infertility. The INVOcell, pictured below, replaces the IVF laboratory and allows conception to take place naturally inside the woman's body. INVO Bioscience's INVOcell device and the INVO process will be much less expensive than traditional IVF and is comparable in pregnancy rate. Also, the INVO procedure is simple so it will be available in physician's offices.
The INVOcell Device The INVOcell device and procedure were developed by Dr. Claude Ranoux. Over 800 clinical cases using prototype devices have been published in the medical literature. The INVOcell is a precisely designed and manufactured device. The INVOcell is manufactured in the U.S. by a company that is ISO-13485 certified. INVO Bioscience has 5 current patents on the INVOcell device and procedure.
“This technology represents an exciting and important new treatment option for infertility.”
Dr. Leo Bonaventura, INVOcell Clinical Investigator and member of INVO Bioscience's Board of Advisors,
Bonaventura Reproductive Medicine, Carmel, member of INVO Bioscience's Board of Advisor
Claude Ranoux, MD, MS - Founder, President and Chief Scientist
More than 30 years of experience in the treatment of infertility; he is the inventor and developer of the INVO procedure and INVOcell device.
(978)-878-9505 ext. 506
Katie Karloff - Chief Executive Officer
Over 25 years of experience in medical device manufacturing, clinical operations, regulatory affairs and quality systems with 13 years at Boston Scientific and 10 years on the senior management teams of start-up organizations.
(978)-878-9505 ext. 504
Robert J. Bowdring - Director
Our former Chief Financial Officer, Rob has a strong history in senior financial management with over 25 years experience as CFO, VP Finance and Controller. Rob has been in both public and private manufacturing and service companies during his career primarily in start up to midsize companies.
Thanks for looking! This information should not be construed as investment advice. All information is provided for informational purposes only. We advise you express your own Due Diligence before making any purchase in this stock.